Analytical Validation of a Serum Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma

Robyn Pescatore, Naphtali Milliken, Thomas King, Dillon Josey, Norma A Palma, Lisa Ford, Keiji Hanada · 2025

Read Analytical Validation of a Serum Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma by Robyn Pescatore, Naphtali Milliken, Thomas King, Dillon Josey, Norma A Palma, Lisa Ford, Keiji Hanada (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12731796.txt.

Description

Robyn Pescatore and co-authors validated in 2025 the lab performance of a blood test panel for early pancreatic cancer. The cancer is usually found late, so a blood signature that catches stage one or two could save lives. Their panel joins a standard marker with four proteins measured by custom lab assays.

The team checked each assay for precision, straight-line response, stability, and interference under national lab guidelines. A test can only enter clinics if every part measures the same way day after day and lab after lab. This groundwork decides whether the promising signature can become a real screening tool.

Catalog record

CREATORRobyn Pescatore, Naphtali Milliken, Thomas King, Dillon Josey, Norma A Palma, Lisa Ford, Keiji Hanada
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12731796

Browse the full library · About the Tower of Babel